Leaderboards/Coronary Interventions and Diagnostics

Coronary Interventions and Diagnostics

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Dominick Angiolillo Angiolillo
University of Florida
2
Bahadir Simsek
Yale New Haven Hospital
3
Filippo Luca Gurgoglione
University of Parma
4
Sung-Jin Hong
Yonsei University
5
Robert F. Riley
Overlake Hospital Medical Center
6
William F Fearon
VA Palo Alto Health Care System
7
Pedro E P Carvalho
Minneapolis Heart Institute Foundation
8
Linzi Chen
Ningbo No. 2 Hospital
9
Rick Volleberg
St. Francis Hospital
10
Athanasios Rempakos
Beaumont Hospital, Troy

Papers

1
Publication in The Lancet (2024) [91 citations, W4402146818]
The Lancet|2024
91 cit.
2
Publication in Journal of the Society for Cardiovascular Angiography & Interventions (2024) [88 citations, W4391406162]
Journal of the Society for Cardiovascular Angiography & Interventions|2024
88 cit.
3
Publication in Future Pharmacology (2024) [21 citations, W4404061296]
Future Pharmacology|2024
21 cit.
4
Publication in Cardiovascular revascularization medicine (2024) [18 citations, W4401059347]
Cardiovascular revascularization medicine|2024
18 cit.
5
Publication in The American Journal of Cardiology (2024) [14 citations, W4405430552]
The American Journal of Cardiology|2024
14 cit.
6
Publication in JACC: Cardiovascular Interventions (2024) [11 citations, W4400273465]
JACC: Cardiovascular Interventions|2024
11 cit.
7
Publication in The American Journal of Cardiology (2025) [9 citations, W4413149081]
The American Journal of Cardiology|2025
9 cit.
8
Publication in JACC Advances (2025) [8 citations, W4409801815]
JACC Advances|2025
8 cit.
9
Lemierre syndrome with pulmonary empyema caused by <i>Prevotella intermedia</i>
BMJ Case Reports|2024
6 cit.
10
Publication in The American Journal of Cardiology (2024) [6 citations, W4403667522]
The American Journal of Cardiology|2024
6 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
George C.M. Siontis
University Hospital of Bern
2
Christopher D. Maroules
The University of Texas Southwestern Medical Center
3
Carlos Collet
Onze Lieve Vrouwziekenhuis Hospital
4
Claudio Chiastra
Politecnico di Torino
5
Susann Beier
UNSW Sydney
6
Michelle O'Donoghue O'Donoghue
Brigham and Women's Hospital
7
Andreas Jörg Schriefl
Graz University of Technology
8
Chuck Simonton
Johnson & Johnson (United States)
9
Tim ten Cate
Zuyderland Medisch Centrum
10
Lorenzo Azzalini
Abbott Northwestern Hospital

Papers

1
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
JAMA|2022
589 cit.
2
Antiplatelet therapy after percutaneous coronary intervention
EuroIntervention|2022
282 cit.
3
Clinical Validation of a Virtual Planner for Coronary Interventions Based on Coronary CT Angiography
JACC. Cardiovascular imaging|2022
101 cit.
4
Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease
JACC: Cardiovascular Interventions|2022
97 cit.
5
Automated segmentation of normal and diseased coronary arteries – The ASOCA challenge
Computerized Medical Imaging and Graphics|2022
92 cit.
6
Generalizability of FDA-Approved AI-Enabled Medical Devices for Clinical Use
JAMA Network Open|2025
70 cit.
7
Influence of Pathophysiologic Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes
Circulation|2024
65 cit.
8
Accuracy of vascular tortuosity measures using computational modelling
Scientific Reports|2022
56 cit.
9
2022 use of coronary computed tomographic angiography for patients presenting with acute chest pain to the emergency department: An expert consensus document of the Society of cardiovascular computed tomography (SCCT)
Journal of cardiovascular computed tomography|2022
45 cit.
10
Procedural Outcomes After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease
Journal of the American Heart Association|2022
42 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Patrick W. Serruys
Erasmus MC
2
Martin B. Leon
Columbia University Irving Medical Center
3
Gregg W. Stone
Cardiovascular Institute of the South
4
Antonio Colombo
Humanitas University
5
Renu Virmani
CVPath Institute
6
Richard E. Kuntz
Brigham and Women's Hospital
7
William Wijns
Ollscoil na Gaillimhe – University of Galway
8
Stephan Windecker
University of Bern
9
Ron Waksman
Clinical Research Institute
10
Miguel Sousa‐Uva
Hospital de Santa Cruz

Papers

1
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
European Heart Journal|2015
8.3k cit.
2
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
New England Journal of Medicine|2010
7.2k cit.
3
Clinical End Points in Coronary Stent Trials
Circulation|2007
5.4k cit.
4
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
New England Journal of Medicine|2016
5k cit.
5
2013 ESC guidelines on the management of stable coronary artery disease
European Heart Journal|2013
4.5k cit.
6
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
New England Journal of Medicine|2009
4.3k cit.
7
2014 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal|2014
4.3k cit.
8
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
New England Journal of Medicine|2003
4.2k cit.
9
A Prospective Natural-History Study of Coronary Atherosclerosis
New England Journal of Medicine|2011
3.3k cit.
10
Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis
Circulation|2002
3.2k cit.

Reagents for Coronary Interventions and Diagnostics

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

E2F4 (E3G2G) Rabbit Monoclonal Antibody

#40291$161,351
View Evidence →
Cell Signaling TechnologyEvidence 66

PKC-delta Antibody

#2058$317
View Evidence →
Cell Signaling TechnologyEvidence 63

Phospho-GSK-3 alpha/beta (Ser21/9) (37F11) Rabbit Monoclonal Antibody

#9327$179,968
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 70

cGAS (E5V3W) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 6 papers
#86793$865
View Evidence →
Agilent/Dako

Macrophage (Concentrate)

#M0633
View Evidence →
Cell Signaling Technology

VWF (D8L8G) Rabbit Monoclonal Antibody

#65707$178,415
View Evidence →